Home » Archive by Category

News

San Diego biotech news from BioSpace, Xconomy, PR Newswire, Marketwired and other sources, click on headlines to read the full story.

Biomarker Discovery Company, Antigen Discovery Inc., Awarded An NIH Phase I Small Business Innovation Research Grant To Develop A Pan-HIV Protein Microarray Chip

October 22, 2014 – 5:00 am | Edit Post

IRVINE, Calif., Oct 22, 2014 /PRNewswire/ — Antigen Discovery Inc. (ADi), a privately held company in Irvine, California, announced the receipt of a National Institutes of Health (NIH) Phase I Small Business Innovation Researchaward (SBIR) fromthe National Institute of Dental…

Avacen Medical Wins FDA Nod For First Medical Device With Internal Game Mode

October 22, 2014 – 5:00 am | Edit Post

Cerus Corporation Secures $30 Million Growth Capital Credit Facility From Oxford FinanceMonitors Proper Device Use and Enhances Patient ComplianceSAN DIEGO, Oct. 22, 2014 /PRNewswire/ — AVACEN Medical announced today that its AVACEN 100 Class II medical device received 510 (k) OTC clearance by the U.S. Food and Drug Administration. This clearance…

Regulus Therapeutics, Inc. Gets Seat At Hepatitis C Table With Impressive Phase 1 Results; Stock Up 99.98% At 12:54PM ET On Wednesday

October 22, 2014 – 5:00 am | Edit Post

Hanson Wade Release: Upcoming World Antibody-Drug Conjugate (ADC) Meeting and Awards in San Diego Highlight California’s Growing Cancer Therapeutics Hub

October 22, 2014 – 5:00 am | Edit Post

SAN DIEGO, Calif., Oct. 21, 2014 /PRNewswire-iReach/ — Antibody-drug conjugates (ADCs) are one of the most exciting new classes of cancer therapeutics because they combine the potency of small molecules with the specificity of antibodies. California’s culture of innovation, as well as access to world class drug discovery and development expertise, has accelerated progress in ADC therapeutics, a market…

Quidel Corporation Reports Third Quarter 2014 Financial Results

October 22, 2014 – 5:00 am | Edit Post

SAN DIEGO, CA–(Marketwired – October 21, 2014) – Highlighted Links Quidel DHI

AVACEN Medical Wins FDA Nod For First Medical Device With Internal Game Mode

October 22, 2014 – 5:00 am | Edit Post

Cerus Corporation Secures $30 Million Growth Capital Credit Facility From Oxford FinanceMonitors Proper Device Use and Enhances Patient ComplianceSAN DIEGO, Oct. 22, 2014 /PRNewswire/ — AVACEN Medical announced today that its AVACEN 100 Class II medical device received 510 (k) OTC clearance by the U.S. Food and Drug Administration. This clearance…

Ivera Medical Corporation Successfully Completes FDA Inspection

October 22, 2014 – 5:00 am | Edit Post

SAN DIEGO, CA–(Marketwired – October 21, 2014) – Ivera Medical Corporation is pleased to report that it successfully completed several days of an exhaustive and intensive review by the Food and Drug Administration (FDA) of Ivera’s manufacturing practices, quality control and regulatory filings. At the conclusion of the inspection, which was prompted by a complaint filed…

As Atlas Splits, Is There A Case To Make In Venture For Specialists?

October 22, 2014 – 3:30 am | Edit Post

Readers of this column who are of a certain age might remember Chrissie Hynde of the Pretenders in black eyeliner, dressed as a diner waitress singing, “I’m special, so special, and I…
[[Click headline to continue reading.]]

Cosmederm gets $50M funding

October 21, 2014 – 4:24 pm | Edit Post

The San Diego company receives the money from UK-based Woodford Investment Management.

Upcoming World Antibody-Drug Conjugate (ADC) Meeting and Awards in San Diego… — SAN DIEGO, Calif., Oct. 21, 2014 /PRNewswire-iReach/ –

October 21, 2014 – 2:34 pm | Edit Post

Antibody-drug conjugates (ADCs) are one of the most exciting new classes of cancer therapeutics because they combine the potency of small molecules with the specificity of antibodies. California’s culture of innovation, as well as access to world class drug discovery and development expertise, has accelerated progress in ADC therapeutics, a market that was $396 million in 2013 and growing at a rate of 48% per year.